NCT04871893View on ClinicalTrials.gov

Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 25, 2022

Primary Completion Date

December 6, 2024

Study Completion Date

December 31, 2024

Conditions
Acute Lung InjuryAcute Kidney InjuryHypercapniaCovid19
Interventions
DEVICE

multiECCO2R blood-gas exchanger

Treatment with the blood-gas exchanger multiECCO2R for CO2 removal

Trial Locations (6)

10117

Charité - Universitätsmedizin Berlin, Berlin

20246

Universitätsklinikum Hamburg, Hamburg

32049

Klinikum Herford, Herford

91054

Universitätsklinikum Erlangen, Erlangen

93053

Universitätsklinikum Regensburg Klinik und Poliklinik für Innere Medizin, Regensburg

93093

Klinikum Donaustauf, Donaustauf

All Listed Sponsors
collaborator

CERES GmbH

INDUSTRY

lead

Fresenius Medical Care Deutschland GmbH

INDUSTRY